Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07224906

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pulmonary Hypertension Cardiovascular Diseases Congestive Heart Failure(CHF) Heart Diseases Heart Failure Heart Valve Diseases Hypertension Hypertension, Pulmonary Lung Diseases Respiratory Tract Diseases Valve Disease, Heart Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Boulder Heart

Boulder, Colorado, 80303, United States

Location status: Recruiting

Location contact

Katharine Adkins

CONTACT

[email protected]

303-442-2395

Scott Blois, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
  • Subjects can be any gender but must be age 18 or older.
  • Subject is able and willing to provide informed consent and HIPAA authorization.
  • Subject is able and willing to meet all study requirements.
  • Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion criteria

  • Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Treatment and study plan

Primary outcomes

  1. Association between device measurements and Pulmonary Capillary Wedge Pressure

    Time frame: Day 1

    The correlation of HemoCept device measurements to Pulmonary Capillary Wedge Pressure (PCWP) measured during right heart catheterization.

Study contacts

Contact information is provided by the study sponsor or research team.

Katharine Adkins

CONTACT

[email protected]

303-442-2395

Sponsors and collaborators

Lead sponsor

HemoCept Inc.

Industry

Registry information

Official study title

Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Nov 5, 2025
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.